Skip to main content

Advertisement

Log in

Treatment of Status Epilepticus: An International Survey of Experts

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

As part of the development of the Neurocritical Care Society (NCS) Status Epilepticus (SE) Guidelines, the NCS SE Writing Committee conducted an international survey of SE experts.

Methods

The survey consisted of three patient vignettes (case 1, an adult; case 2, an adolescent; case 3, a child) and questions regarding treatment. The questions for each case focused on initial and sequential therapy as well as when to use continuous intravenous (cIV) therapy and for what duration. Responses were obtained from 60/120 (50%) of those surveyed.

Results

This survey reveals that there is expert consensus for using intravenous lorazepam for the emergent (first-line) therapy of SE in children and adults. For urgent (second-line) therapy, the most common agents chosen were phenytoin/fosphenytoin, valproate sodium, and levetiracetam; these choices varied by the patient age in the case scenarios. Physicians who care for adult patients chose cIV therapy for RSE, especially midazolam and propofol, rather than a standard AED sooner than those who care for children; and in children, there is a reluctance to choose propofol. Pentobarbital was chosen later in the therapy for all ages.

Conclusion

There is close agreement between the recently published NCS guideline for SE and this survey of experts in the treatment of SE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120–2.

    Article  PubMed  CAS  Google Scholar 

  2. Brophy GB, Bell R, Alldredge A, Bleck TP, Claassen J, LaRoche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.

    Google Scholar 

  3. Bleck TP. Refractory status epilepticus. Curr Opin Crit Care. 2005;11(2):117–20.

    Article  PubMed  Google Scholar 

  4. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8.

    Article  PubMed  CAS  Google Scholar 

  5. Cornfield DN, Tegtmeyer K, Nelson MD, Milla CE, Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics. 2002;110(6):1177–81.

    Article  PubMed  Google Scholar 

  6. Kinoshita H, Nakagawa E, Iwasaki Y, Hanaoka S, Sugai K. Pentobarbital therapy for status epilepticus in children: timing of tapering. Pediatr Neurol. 1995;13(2):164–8.

    Article  PubMed  CAS  Google Scholar 

  7. Holtkamp M, Othman J, Buchheim K, Meierkord M. Predictors and prognosis for refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534–9.

    Article  PubMed  CAS  Google Scholar 

  8. Sakuma H. Acute encephalitis with refractory, repetitive partial seizures. Brain Dev. 2009;31(7):510–4.

    Article  PubMed  Google Scholar 

  9. Sahin M, Menache C, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42(11):1461–7.

    Article  PubMed  CAS  Google Scholar 

  10. Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of acute symptomatic refractory status epilepticus in children. Neurology. 2003;61(3):398–401.

    Article  PubMed  Google Scholar 

  11. Kramer U, Shorer Z, Ben-Zeev B, Lerman-Sagie T, Goldberg-Stern H, Lahat E. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol. 2005;20(3):184–7.

    PubMed  Google Scholar 

  12. Mikaeloff Y, Jambaque I, Hertz-Pannier L, Zamfirescu A, Adamsbaum C, Plouin P, Dulac O, Chiron C. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res. 2006;69(1):67–79.

    Article  PubMed  CAS  Google Scholar 

  13. Baxter P, Clarke A, Cross H, Harding B, Hicks E, Livingston J, Surtees R. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure. 2003;12(6):379–87.

    Article  PubMed  Google Scholar 

  14. Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, Ong BK. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore. 2005;34(7):417–20.

    PubMed  CAS  Google Scholar 

  15. van Baalen A, Hausler M, Boor R, Rohr A, Sperner J, Kurlemann G, Panzer A, Stephani U, Kluger G. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51(7):1323–8.

    Article  PubMed  Google Scholar 

  16. Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, Nabbout R, Kluger G, Lin JJ, van Baalen A. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to James J. Riviello Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riviello, J.J., Claassen, J., LaRoche, S.M. et al. Treatment of Status Epilepticus: An International Survey of Experts. Neurocrit Care 18, 193–200 (2013). https://doi.org/10.1007/s12028-012-9790-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-012-9790-1

Keywords

Navigation